Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Docmode Health Technologies's enterprise value is ₹166.6 Mil.
Docmode Health Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2.0 Mil. Therefore, Docmode Health Technologies's EV-to-EBITDA for today is 81.63.
The historical rank and industry rank for Docmode Health Technologies's EV-to-EBITDA or its related term are showing as below:
NSE:DHTL's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.07 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Docmode Health Technologies (NSE:DHTL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Docmode Health Technologies's PE Ratio (TTM) for today is calculated as:
Docmode Health Technologies's share price for today is ₹35.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Docmode Health Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-6.450.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:DHTL vs VEEV, BTSG, TEM: EV-to-EBITDA Comparison
For the Health Information Services subindustry, Docmode Health Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Docmode Health Technologies EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Docmode Health Technologies's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Docmode Health Technologies's EV-to-EBITDA falls into.
Docmode Health Technologies's current Enterprise Value is ₹166.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Docmode Health Technologies's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₹2.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Docmode Health Technologies (NSE:DHTL) has a EV-to-EBITDA of 81.63 as of Aug. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Docmode Health Technologies.
Is Docmode Health Technologies' EV-to-EBITDA too high?
Docmode Health Technologies' current EV-to-EBITDA is 81.63. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.07. Docmode Health Technologies' value of 81.63 is 637.4% above this industry median. Overall, Docmode Health Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Docmode Health Technologies' EV-to-EBITDA compare to VEEV and BTSG?
Docmode Health Technologies' EV-to-EBITDA of 81.63 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBITDA is 11.07. Docmode Health Technologies' value of 81.63 is 637.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.07, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Docmode Health Technologies's current EV-to-EBITDA of 81.63 is 637.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Docmode Health Technologies. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Docmode Health Technologies's current EV-to-EBITDA is 81.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Docmode Health Technologies stock overvalued right now?
Docmode Health Technologies (NSE:DHTL) has a current EV-to-EBITDA of 81.63. The current EV-to-EBITDA is 81.63 and 637.4% above the Healthcare Providers & Services industry median of 11.07. Docmode Health Technologies' overall GF Score™ is 14/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Docmode Health Technologies (NSE:DHTL), the current EV-to-EBITDA is 81.63 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Docmode Health Technologies Ltd is engaged in the business of providing comprehensive & interactive learning programs for healthcare professionals through e-Learning measures and providing online CME (continuous medical education) Certification Courses and designing & conducting surveys, quizzes, questionnaires, etc. for collecting data insights related to the healthcare industry Its business segment is engaged in providing vocational training, DocMode is a platform that provides authoritative, comprehensive, and interactive learning programs for Health Professionals - Doctors, Nurses, Allied and Medical Students - across the world. The company has a new segments namely publishing of Medical books, trading of medical books and journals, conducting customised and inhouse events.
14GF Score
Get the complete analysis for NSE:DHTL
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DHTL has been successfully added to your 
